Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06942468Phase 4Not yet recruiting
Phase 4, randomised trial of phenytoin in atrophic acne scars (2 arms), sponsored by Assiut University. Primary endpoint: Quantitative Global Acne Scarring Score. Planned start Jul 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06942468.